相关实验视频
Updated: Mar 10, 2026

09:45
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
7.6K
LncRNAs:肺癌辐射敏感性的关键调节器和分子机制
Yuhan Chen1, Jiajie Shi1, Changcheng Qin1
1School of Public Health, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Open medicine (Warsaw, Poland)
|March 9, 2026
概括
长非编码RNAs (lncRNAs) 通过影响DNA修复和亡来调节肺癌细胞的放射敏感性. 针对 lncRNAs 提供了一种有前途的策略,以克服放射电阻并改善放射治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 肺癌是全球癌症死亡的主要原因之一.
- 放射治疗是主要的治疗方法,但瘤的放射电阻限制了它的有效性.
- 长非编码RNAs (lncRNAs) 正在成为癌细胞辐射敏感性的关键调节者.
研究的目的:
- 审查 lncRNAs 在调节肺癌辐射敏感性的分子机制.
- 评估lncRNAs作为放射治疗的预测生物标志物的潜力.
- 探索基于 lncRNA 的策略来克服放射电阻.
主要方法:
- 关于 lncRNAs 和肺癌辐射敏感性的综合文献综述.
- 通过lncRNAs调节的分子途径 (DNA修复,细胞亡,细胞循环,瘤微环境) 的分析.
- 评价 lncRNAs作为生物标志物和治疗点.
主要成果:
- lncRNAs通过各种生物过程调节辐射敏感性.
- 特定的lncRNA与对放射治疗的敏感性和耐药性有关.
- lncRNAs在DNA损伤修复,细胞亡,细胞循环和瘤微环境重塑中发挥作用.
结论:
- lncRNAs是肺癌辐射敏感性的关键调节者.
- lncRNAs有可能成为放射治疗反应的预测生物标志物.
- 针对 lncRNAs 可能会提高放射治疗的疗效,并克服精确医学中的电阻.
相关概念视频
lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs
3.8K
3.8K
Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Negative Regulator Molecules
38.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Types of RNA
73.5K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
73.5K
MicroRNAs
24.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K

